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ABSTRACT 1 
 2 
Objective: Given the legalization of recreational cannabis in 2012 in Washington State and recent 3 
mixed results regarding the effects of cannabis on driver safety, we examine the link between 4 
Delta-9-Tetrahydrocannabinols (THC) and driver’s behavior, including speeding and driver errors 5 
which may have contributed to a particular fatal crash.  6 
 7 
Methods: The current study utilized data from the Washington State Fatality Analysis Reporting 8 
System Analytical File (WA FARS) in years 2008-2016. A series of logistic regression were 9 
employed to compare THC positive and negative drivers, as well as drivers who tested positive for 10 
other intoxicants.  11 
 12 
Results: The results of the study were mixed as Delta-9 THC positively predicted speeding, but 13 
not other driver errors. Interestingly, Carboxy THC, a non-psychoactive chemical that can be 14 
detected for a longer period of time, was a significant predictor of both speeding and driver errors.  15 
 16 
Conclusions: This research further demonstrates that cannabis is a risk factor for fatal crashes, 17 
though it is not nearly a risk factor of the same magnitude as alcohol. Additional research is needed 18 
to better understand why Carboxy THC is a stronger and more robust predictor of poor driving 19 
behavior than Delta-9 THC.  20 
 21 
 22 
 23 
Keywords: Delta-9 THC, Carboxy THC, Speeding, Driver errors, FARS24 
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INTRODUCTION 1 
Considerable research has examined the role of cannabis in traffic safety and crashes, with some 2 
research suggesting that cannabis is an important risk factor (1-4) and other studies finding little 3 
to no relationship between cannabis consumption and traffic crashes (5,6). The mixed results are 4 
noteworthy, given that early evidence highlighted the link between cannabis consumption and 5 
reductions in driving-related skills, including coordination, attention, and reaction time, with 6 
greater skill reduction occurring at higher doses. Many of these same early studies noted that 7 
drivers under the influence of cannabis were aware of the effects and drive more carefully to 8 
compensate (for a review, see 7). To date, research tends to suggest that cannabis is a “low to 9 
medium” level risk factor for motor vehicle crashes (4, p.1348), but that cannabis when used in 10 
conjunction with alcohol was a much stronger risk factor (8).  11 
Much of the prior literature showing this “low to medium” effect on the likelihood of 12 
crashing is based on simulated driving programs or road experiments. Yet given the potential 13 
increased use of cannabis following legalization in states like Washington, more work remains to 14 
be done examining the link between cannabis consumption and specific driving errors and 15 
behaviors in actual fatal crashes in a state where blood testing for cannaboids is increasingly 16 
common. We attempt to address this gap in the literature. Specifically, we examine the link 17 
between positive tests for Delta-9-Tetrahydrocannabinols (THC) and Carboxy-THC and 18 
dangerous driving behaviors, including speeding and driver errors using Fatality Analysis 19 
Reporting System (FARS) and toxicology results from Washington State. Though FARS data only 20 
include fatal crashes (and thus cannot be used to examine the causal connection between cannabis 21 
and crashes generally), the identification of  links between cannabis consumption and risky driving 22 
behaviors would both support prior literature which identifies cannabis use as a crash risk factor 23 
and could also highlight the manner in which cannabis use affects driving safety. Based on prior 24 
research, we hypothesize that cannabis use, as evident by a positive blood test for THC or Carboxy-25 
THC, increases the likelihood that a driver involved in a fatal crash was speeding or committed 26 
other driver errors. Moreover, we hypothesize that the effects of cannabis on these outcomes are 27 
greater when used in conjunction with alcohol and/or other drugs.  28 
 29 
Background 30 
While more recent epidemiological research typically finds that cannabis consumption is a 31 
significant driving impairment factor (9), the degree of this effect and its link to THC levels in the 32 
bloodstream of drivers is not yet fully established in the research or the law (10-12). Much of the 33 
current discussion revolves around legal thresholds, with Logan et al. (2016, p. 5) noting that “a 34 
quantitative threshold for per se laws for THC following cannabis use cannot be scientifically 35 
supported.” The unresolved nature of research on when cannabis use results in driver impairment 36 
has real world implications. For example, in a recent state appellate court decision in Arizona the 37 
judge ruled that a driver with a medical cannabis card who had 26.9 ng/mL of THC in his blood 38 
could not be deemed drugged because the medical science about the level of THC needed to impair 39 
a driver was not settled among medical practitioners (13). The public, as well, is still uncertain 40 
about the cannabis-traffic link. For example, in a 2014 roadside survey conducted for the National 41 
Highway Traffic Safety Administration by the Pacific Institute for Research and Evaluation in 42 
Washington, it was revealed that a majority (61.9%) of drivers who admit they use cannabis believe 43 
that cannabis does not adversely affect their driving (14-15). 44 
Yet the need for additional research on cannabis and traffic safety is perhaps more pressing 45 
than ever, given the increased trend toward cannabis decriminalization and legalization across the 46 
United States. Indeed, research documented that the prevalence of cannabis in drivers and 47 
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especially in fatal crashes was increasing before states began to experiment with recreational 1 
cannabis laws (16-17). It is difficult to parse out whether this increase in cannabis-involved driving 2 
was a reflection of a shift in behavior or a shift in testing, yet research documents some increase 3 
in cannabis-positive tests for drivers following the passage of medical cannabis laws (18-20). Most 4 
of the notable increases in cannabis-positive test results in states with medical cannabis laws 5 
occurred in fatal crashes where driver toxicology outcomes are readily available. This is despite 6 
other research indicating that medical cannabis laws and the presence of medical marijuana 7 
dispensaries were negatively related to traffic fatalities overall (21). This is perhaps because 8 
research suggests that medical marijuana laws had little to no impact on cannabis use among young 9 
adults (22).  10 
A considerable amount of cannabis is being sold in states which have legalized recreational 11 
cannabis. In Washington State over $1 billion dollars in sales have been made (23), with income 12 
from taxes and licensing rising to $319 million in 2017 alone (increasing from $189 million in 13 
2016) (22, 24, p.15). Early evidence suggests that at least initially, legalization increased use 14 
among minors in Washington State, but not in Colorado (25, 26). Still, given the prevalence of 15 
young drivers in fatal crashes (27) and the potential for increased usage among this population, it 16 
is reasonable to infer that recreational marijuana laws could increase the prevalence of drivers 17 
under the influence of cannabis. The potential for increased traffic crashes and fatalities was, in 18 
fact, a central part of the argument against cannabis legalization in states like Washington (28). 19 
Importantly, research shows that since legalization the number of cannabis related driving cases, 20 
both Delta-9-THC and Carboxy-THC in Washington State, have increased markedly (29). To date, 21 
however, no research has examined the link between cannabis consumption and risky driving 22 
behaviors in a state with legalized recreational cannabis.  23 
 24 
METHODS 25 
 26 
Data 27 
Data for studying traffic fatalities are commonly drawn from the National Highway Traffic Safety 28 
Administration’s Fatality Analysis Reporting System (NHTSA FARS), yet Pollini et al. (2015) 29 
note that drug information is relatively sparse in the national FARS data (see also 30). Here, we 30 
use data from the Washington State Fatality Analysis Reporting System Analytical File (WA 31 
FARS) and supplement it with toxicology outcomes from the Washington State Laboratory on 32 
drivers. The FARS data provide information on all fatal crashes in the State of Washington and are 33 
organized into person and incident-level records. Unlike the NHTSA FARS, the WA FARS 34 
includes specified THC results (Delta-9-THC versus Carboxy-THC) and drug blood levels for all 35 
drivers in fatal crashes who were blood tested for intoxicants. Conversely, NHTSA FARS can only 36 
be used to identify the presence of unspecified cannabinoids and does not include drug levels (30).  37 
For the purposes of our analyses, the fatal crash-involved driver (both surviving and 38 
deceased) is the unit of analysis and we merge data about these incidents with data about the 39 
toxicology result of the driver. We utilize WA FARS data from January 2008 to December 2016, 40 
as blood test derived THC levels are not available before this time period. There were a total of 41 
10,155 individuals of all types involved in fatal crashes in Washington from 2008 to 2016. Among 42 
these individuals, 5,931 drivers were involved in fatal crashes, of which 2,432 were only blood 43 
tested for intoxicants with 2,425 complete cases. 44 
 45 
Driver Error Outcome Variables 46 
The WA FARS data includes a variety of measures that might reflect driver culpabilities, like 47 
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evidence of speeding, lane deviations, distraction, and other driving errors. Since many of these 1 
individual variables occurred relatively infrequently, we combined these measures into two 2 
dichotomous variables representing driver culpability: 1) speeding and 2) driver errors (identified 3 
by police). The first dependent variable, speeding was dichotomous in nature, but the other 4 
outcome, driver errors, contains several sub-categories. For example, in the driver error variable, 5 
there were 34 sub-types of driving errors or fault, such as driving in an erratic reckless, negligent 6 
manner, or abrupt speed change, driving on the wrong side, improper lane changing, intentional 7 
illegal driving on the road shoulder, failure to yield or obey the signal, and overcorrecting. These 8 
measures were dummy coded into a dichotomous variable representing driver error. 9 
 10 
Covariates of Fatal Crash Risks  11 
In addition to measures of driver error, the WA FARS data also includes information on the 12 
presence of alcohol and other drugs in the blood by the driver. Given that prior research has 13 
highlighted the confounded nature of cannabis and alcohol (8, 17), we include measures of both, 14 
as well as of other drugs in order to examine whether Delta-9-THC and Carboxy-THC have an 15 
independent and/or contingent relationship with speeding and driver errors. We included two 16 
dummy variables that indicate whether the driver tested positive for Delta-9-THC at less than 5 17 
nanograms per mL of blood or 5 or more nanograms per mL of blood (the per se limit in 18 
Washington state). In addition, we include a dummy variable measure of Carboxy-THC (hereafter 19 
referred to simply as Carboxy) in our analysis. Carboxy results are included in the drug tests for 20 
fatal crashes in Washington and are indicative that a person had consumed cannabis, but perhaps 21 
not recently, as Carboxy is an non-psychoactive metabolite formed after cannabis consumption 22 
which can stay in the bloodstream for a longer period of time (31), with some research suggesting 23 
Carboxy can be detected up to 30 days after consumption (29). Given that all Delta-9-THC positive 24 
drivers, regardless of whether they were above or below the per se limit, also include positive 25 
results for Carboxy, we constructed a modified dummy variable for Carboxy that was scored a 1 26 
if only Carboxy (and not Delta-9 THC) were positive in the test results. Thus, a positive result 27 
(either below or above the per se limit) for Delta-9-THC indicates recent consumption and 28 
potential impairment, while a positive result for Carboxy indicates less recent consumption.  29 
 In order to measure alcohol impairment, we include two dummy variables that indicate 30 
whether the driver’s blood alcohol content (BAC) was greater than or equal to 0.08 (the per se 31 
limit in Washington state) or less than 0.08. In addition, we constructed a single dummy variable 32 
indicating whether the driver tested positive for other drugs, including narcotics, stimulants, 33 
hallucinogens, phencyclidine, inhalants, and other drugs. As a robustness check, we estimated all 34 
of the models below using actual Delta-9-THC and BAC levels instead of just the dummy variable 35 
indicators. Compared to these results, however, results across all the models using dummy 36 
variables were generally better with improved goodness-of-fit logistic models. Thus we only 37 
present results with dummy variables of alcohol, Delta-9-THC, and Carboxy in this paper.  38 
 We also include a variety of driver characteristics in our modeling strategy. Specifically, 39 
we include driver’s age (in years), gender (where 1 equals male and female is the reference 40 
category), whether the driver had an active license (1= licensed, 0 = unlicensed), and prior traffic 41 
convictions (including previous DWIs, driver’s license suspensions, and speeding citations over 42 
past three years). These variables are included as control variables, as these factors might also be 43 
linked to driver speeding and errors. Table 1 presents descriptive statistics for all of the outcome 44 
and driver characteristics variables. 45 
 46 
 47 
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TABLE 1 Outcome Measures and Driver Characteristics (N = 5,915)a 1 
Variable Mean/% SD Range 
Outcome Measures    
   Speeding  0.25 0.43 0-1 
   Driving error (identified by police) 0.27 0.45 0-1 
Driver Characteristics    
   Age (year)  42.45 18.43 16-99 
      26-35 19.0%   
      36-45 15.3%   
      46-55 16.2%   
      56-65 13.4%   
      Over 65 12.7%   
  Gender (1 = male)  0.75 0.43 0-1 
  Unlicensed driver  0.13 0.33 0-1 
  Driver History (during the previous three years)    
     Driving while intoxicated (DWI) 0.03 0.17 0-1 
     Driver license suspensions 0.19 0.39 0-1 
     Speeding convictions 0.27 0.44 0-1 
     Other traffic convictions 0.32 0.47 0-1 
Drug and Alcohol Involvement    
     Total number of blood tested drivers for intoxication 42.0%   
     Alcohol positive    
        BAC < .080 0.04 0.18 0-1 
        BAC > .080 0.19 0.39 0-1 
     Delta-9-THC positive     
        THC < 5.00 0.03 0.17 0-1 
        THC > 5.00 0.04 0.20 0-1 
     Carboxy THC positive (without Delta-9-THC) 0.03 0.18 0-1 
     Other drugsb positive (except for cannabinoid) 0.12 0.33 0-1 
Note: a Drivers in fatal crashes in the state of Washington FARS data, 2008-2016. b other drugs include narcotics, 2 
depressants, stimulants, hallucinogens, phencyclindine, inhalants, and other unknown forms of drugs. 3 
 4 
 5 
In addition to these driver characteristics, the WA FARS data includes a number of factors related 6 
to the context of fatal crashes. Given that weather, road, and vehicle conditions might also affect 7 
driver behavior, we include measures of these variables in our models and crash specific factors 8 
as additional control variables. Descriptive statistics for these environmental factors are 9 
presented in table 2. 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
Woo, Willits, Stohr, Hemmens, Hoff   7 
 
7 | P a g e  
 
TABLE 2 Environmental Contexts of Fatal Crashes (N = 5,915)a 1 
Variable Mean/% SD Range 
Natural Conditions    
   Weather condition    
        Clear 71.8%   
    Cloudy 12.9%   
        Rain 10.9%   
        Fog/smoke  2.2%   
        Snow  2.2%   
   Time of crash (1 = night: 5 A.M. to 5 P.M.) 0.40 0.49 0-1 
Road Conditions     
   Road alignment (1 = Straight) 0.70 0.46 0-1 
   Road grade (1 = Level)  0.66 0.47 0-1 
   Intersection involved  0.27 0.44 0-1 
   Surface type    
       Concrete 11.0%   
       Asphalt 85.8%   
       Others (brick, slag, stone, etc.) 3.2%   
   Surface condition    
       Dry 73.8%   
       Wet or Water 20.3%   
       Snow or Frost  4.3%   
       Others (sand, dirt, mud, oil, etc.)  1.6%   
   Posted speed limit  46.37 12.67 5-70 
   Number of traffic lanes in crash 2.46 0.93 1-5 
Drivers’ Vehicle Conditions    
   Vehicle type     
       Motorcycle 11.7%   
       Medium/heavy truck  5.8%   
       Passenger vehicle (sedan, SUV, van, light truck) 80.0%   
       Others (bus, motorhome, etc.)  2.6%   
Other External Conditions    
   Number of occupants in vehicle   1.51 0.91 1-5 
   Number of vehicles in crash 1.81 0.81 1-4 
   Number of non-motorists in crash 0.13 0.34 0-1 
   Lap and shoulder belt used 0.62 0.49 0-1 
   Heavy truck involved 0.11 0.32 0-1 
   Head-on involved 0.20 0.40 0-1 
   Traffic control device present 0.14 0.35 0-1 
Note: a Drivers in fatal crashes in the state of Washington FARS data, 2008-2016 2 
 3 
 4 
Analytic Strategy 5 
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Since each of the outcome variables (speeding and driver error) are measured dichotomously, we 1 
present a set of two logistic regression models examining main effects, each with robust standard 2 
errors. As the WA FARS data includes a number of factors that might be predictive of the outcome 3 
variables (see Tables 1 and 2), we utilized a stepwise backward selection process for independent 4 
variables, based on prior evidence and literature. We began by estimating two regressions with all 5 
independent variables presented in Tables 1 and 2, then removed independent variables that were 6 
not significant at the p value less than .10, except for a couple of non-significant variables which 7 
have been found and documented as substantial factors related to fatal crashes, such as gender, 8 
time of crash, alcohol BAC test positive, and Delta-9-THC/Carboxy/other drugs positive. In order 9 
to ensure that our model selection process did not unduly affect our results, we compared the 10 
results of our backwards selection models to the full models, which were substantively similar, 11 
though more cumbersome to present (available upon request).  12 
Next, in order to explore the possibility of an interactive relationship between Delta-9-THC, 13 
Carboxy, alcohol and other drugs, we also estimated a series of interaction models for each 14 
outcome variable. In summary, we examined the following interactions: Delta-9-THC by BAC, 15 
Carboxy by BAC, Delta-9-THC by Other Drugs, Carboxy by Other Drugs, BAC by Other Drugs, 16 
and three-way interactions examining Delta-9-THC by BAC by Other Drugs and Carboxy by BAC 17 
by Other Drugs. Following best practices with interaction modeling, we first estimated each 18 
potential interaction and two-way interaction in separate models and included all nested two-way 19 
interactions in the models containing the three-way interactions (32).  20 
Lastly, we also conducted sub-group analyses on 1) drivers who were given a blood test 21 
for drugs (n=2,425, accounting for listwise deletion); 2) drivers who were given a blood test for 22 
drugs and tested positive for alcohol (n=860); and 3) drivers who were given a blood test for drugs 23 
and tested positive for alcohol greater than or equal to 0.08 (n=714). Though the WA FARs data 24 
provide more information on chemicals present in the blood than other data, not all drivers in 25 
Washington are tested. In the full sample models, all drivers who were not tested would be counted 26 
as having not consumed any substances, yet it is possible that some of these untested drivers had 27 
in fact used drugs or alcohol. These sub-group models provide a more direct comparison between 28 
clean and potentially impaired drivers, though they do so at the expense of omitting a great number 29 
of drivers who were likely unimpaired.  30 
 31 
RESULTS 32 
 33 
Speeding Models 34 
Results for the main effects and the three interaction models where speeding is regressed on driver 35 
characteristics, contextual factors, and drug and alcohol involvement are presented in Table 3. The 36 
results using all drivers involved in fatal crashes indicate that younger drivers, males, motorcycle 37 
drivers, and drivers who test positive for alcohol, Carboxy or Delta-9-THC or other drugs, were 38 
more likely to be speeding when involved in a fatal crash than drivers without these risk factors. 39 
In addition, driving in poor weather conditions (e.g., fog/smoke and snow) and on curvy wet roads 40 
were also risk factors for speeding during fatal crashes. The odds of speeding for drivers who tested 41 
positive for Delta-9-THC (over the 5 nanograms per mL per se limit) were 48% more likely to be 42 
speeding than those who did not test positive for Delta-9-THC at all, controlling for other factors. 43 
There was not a similar effect for those drivers who tested positive for Delta-9-THC at a level less 44 
than the per se limit. The presence of Carboxy, however, was also statistically significantly 45 
associated with speeding:  The odds of speeding for drivers who tested positive for Carboxy were 46 
54% greater than for those who did not, controlling for other factors. 47 
 48 
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TABLE 3 Logit Models of Drug and Alcohol on Speeding (n = 5,310 drivers from 2008-2016 WA FARS data) 1 
. Main Effects Model Interaction Model 1 Interaction Model 2 Interaction Model 3 
Covariates Logit 
(Robust SE) 
  OR Logit 
(Robust SE) 
  OR Logit 
(Robust SE) 
  OR Logit 
(Robust SE) 
  OR 
Driver Characteristics          
     Age  -.03(.00) 0.97*** -.03(.00) 0.97*** -.03(.00) 0.97*** -.03(.00) 0.97*** 
     Gender (1 = male)   .40(.10) 1.49***   .39(.10) 1.48***   .40(.10) 1.48***   .40(.10) 1.49*** 
     Prior Speeding convictions  
     (in the past three years) 
  .10(.08) 1.11   .10(.08) 1.11   .11(.08) 1.11   .11(.08) 1.11 
Natural Conditions         
     Weather      
     condition 
Clear (reference)      --   --      --   --      --   --      --   -- 
Cloudy   .07(.12) 1.07   .07(.12) 1.07   .07(.12) 1.07   .07(.12) 1.07 
Rain -.33(.17) 0.72* -.33(.17) 0.72* -.34(.17) 0.72* -.34(.17) 0.71* 
Fog/Smoke   .83(.28) 2.29**   .82(.29) 2.28**   .84(.29) 2.31**   .83(.29) 2.28** 
Snow 1.09(.29) 2.98*** 1.11(.29) 3.03*** 1.11(.29) 3.04*** 1.11(.29) 3.04*** 
     Time of crash (1 = night)   .04(.08) 1.04   .03(.08) 1.03   .03(.08)  1.03   .03(.08)  1.03 
Road Conditions         
     Road alignment (1 = straight) -.73(.08) 0.48*** -.73(.08) 0.48*** -.73(.08) 0.48*** -.73(.08) 0.48*** 
     Road grade (1 = level) -.20(.08) 0.82*   .20(.08) 0.82* -.21(.08) 0.81* -.20(.08) 0.82* 
     Surface condition (1 = dry) -.67(.12) 0.51*** -.66(.12) 0.52*** -.67(.12) 0.51*** -.67(.12) 0.51*** 
     Surface type (1 = Asphalt) -.17(.12) 0.84 -.17(.12) 0.85 -.17(.12) 0.84 -.17(.12) 0.85 
     Intersection involved -.44(.10) 0.65*** -.44(.10) 0.65*** -.43(.10) 0.65*** -.44(.10) 0.65*** 
     Posted speed limit -.02(.00) 0.98*** -.02(.00) 0.98*** -.02(.00) 0.98*** -.02(.00) 0.98*** 
Drivers’ Vehicle Conditions         
     Vehicle  
       type 
Passenger vehicle 
(Reference) 
     --   --      --   --      --   --      --   -- 
Heavy truck -.60(.23) 0.55** -.59(.23) 0.56* -.58(.23) 0.56* -.58(.23) 0.56* 
Motorcycle 1.21(.11) 3.37*** 1.21(.12) 3.35*** 1.21(.12) 3.36*** 1.21(.12) 3.34*** 
Others -.11(.34) 0.89 -.11(.34) 0.90 -.11(.34) 0.90 -.11(.34) 0.89 
\Other External Conditions         
     Number of occupants in vehicle   .11(.04) 1.11** .11(.04)  1.12**   .11(.04)  1.12**   .11(.04)  1.12** 
     Number of vehicles in crash -.49(.06) 0.62*** -.48(.06) 0.62*** -.49(.06) 0.62*** -.48(.06) 0.62*** 
Drug and Alcohol Involvement         
     BAC < .080   .89(.17) 2.43*** .88(.17) 2.41***   .86(.17) 2.37***   .86(.17) 2.36*** 
     BAC > .080 1.26(.10) 3.51*** 1.37(.11) 3.94*** 1.36(.11) 3.88*** 1.34(.11) 3.84*** 
     THC < 5.00   .12(.20) 1.13 .11(.20) 1.12   .11(.20) 1.11   .11(.20) 1.11 
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     THC > 5.00 .39(.17) 1.48*   .37(.17) 1.45*   .58(.19) 1.78**   .59(.19) 1.80** 
     Carboxy only without THC .43(.18) 1.54*   .42(.18) 1.52*   .41(.18) 1.51*   .65(.23) 1.91** 
     Other drugsa .59(.10) 1.80***   .76(.12) 2.13***   .81(.12) 2.24***   .85(.12) 2.35*** 
Interactionsb         
     BAC >.080*Other drugs    --   -- -.57(.22) 0.57**  -.54(.22) 0.58* -.53(.21) 0.59* 
     THC > 5.00*Other drugs    --   --      --  -- -.80(.37) 0.45* -.85(.37) 0.43* 
     Carboxy*Other drugs    --   --      --  --      --  -- -.72(.38) 0.49† 
       
Model χ2 1455.405*** 1460.003*** 1460.432*** 1464.263*** 
Nagelkerke R2 .380 .381 .382 .383 
Note: Significant interaction terms in the models are presented. OR = odds ratios. BAC = blood alcohol concentration. THC = Delta-9-tetrahydrocannabinol. a other 1 
drugs include narcotics, depressants, stimulants, hallucinogens, phencyclindine, inhalants, and other unknown types of drugs. b Two interaction terms, 2 
BAC<.080*Carboxy and BAC<.080*Carboxy*Other drug were excluded due to multicollinearity and the zero cell issue. Sample sizes vary by models due to the use 3 
of a list-wise deletion method. 4 
† p <.1, *p <.05, **p <.01, ***p <.001 5 
 6 
 7 
            Though this is a substantial increase, it falls far short of the magnitude of the effect of alcohol on speeding. Drivers who tested 8 
below the 0.08 limit were 143% more likely to have been speeding and drivers who tested positive equal to or over the 0.08 BAC limit 9 
were 251% more likely to have been speeding during a fatal crash than drivers who did not. On the other hand, drivers with elevated 10 
BACs and those who tested positive for other drugs were less likely to be speeding during a fatal crash than drivers who only had a 11 
positive BAC as noted by the negative coefficients for the interactions between BAC and other drugs. These data indicate that the 12 
addition of “other drugs” to alcohol tends to dampen the tendency to speed. 13 
The interaction models indicate no statistically significant two- or three-way interaction between Delta-9-THC and alcohol. These 14 
results indicate that drivers who were under the influence of both cannabis and alcohol simultaneously were no more likely to speed in fatal 15 
accidents than other drivers. There is however a statistically significant interaction between other drugs and BAC equal to or over the 0.08 16 
limit, Delta-9-THC equal to or over the per se limit, and Carboxy in interaction models 1, 2, and 3 (respectively). These interaction were 17 
negative. In terms of cannabis, this suggests that drivers who had used cannabis recently and blood tested positive for both Delta-9-THC 18 
and another other drug were less likely to speed, though it should be noted that the overall relationship between Delta-9 THC, Carboxy, 19 
alcohol, other drugs and the outcome variable speeding remain positive. These interactions only provide modest improvements to model 20 
fit as evidenced by the small increases in Nagelkerke R2 values. Put simply, these results suggest that consumption of any of these substances 21 
increases the likelihood that a driver was speeding during a fatal crash, but that the consumption of multiple substances does not further 22 
increase this risk and, in fact, might diminish, but not eliminate the risk caused by one substance. 23 
In order to explore the possible relationship between certain types of drivers and blood toxicology results on speeding, sub-group analysis 24 
was conducted using the same logit models on three sub-groups of drivers: 1) drivers who were given a blood test for drugs (n=2,201, 25 
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which is lower than the 2432 due to listwise deletion); 2) drivers who were given a blood test for drugs and tested positive for alcohol 1 
(n=763); and 3) drivers who were given a blood test for drugs and tested positive for alcohol greater than or equal to 0.08 (n=634). The 2 
results are presented in table 4. 3 
 4 
 5 
TABLE 4 Sub-Group Analysis: Logit Models of Drug and Alcohol on Speeding 6 
 Blood Tested Drivers (n=2,201) BAC Positive Drivers (n=763) BAC >.08 Drivers (n=634) 
Covariates      Logit 
(Robust SE) 
OR      Logit  
(Robust SE) 
OR      Logit  
(Robust SE) 
OR 
Driver Characteristics        
     Age  -.04(.00) 0.96*** -.05(.01) 0.96***   -.05(.01) 0.96*** 
     Gender (1 = male)   .48(.14) 1.61**   .66(.22) 1.93**    .82(.24) 2.26** 
     Prior Speeding convictions  
     (in the past three years) 
  .00(.12) 1.00 -.07(.18) 0.94   -.11(.20) 0.90 
Natural Conditions       
     Weather      
     condition 
Clear (reference)      --   --       --   --        --   -- 
Cloudy   .01(.18) 1.01 -.11(.26) 0.89    .12(.29) 1.12 
Rain -.22(.25) 0.80 -.41(.39) 0.66   -.15(.44) 0.86 
Fog/Smoke   .41(.39) 1.50   .37(.64) 1.45    .64(.68) 1.89 
Snow   .64(.45) 1.90 -1.37(.83) 0.25† -1.24(.79) 0.29 
     Time of crash (1 = night) -.04(.12) 0.97    .09(.19) 1.09   -.08(.22)  0.92 
Road Conditions       
     Road alignment (1 = straight) -.85(.12) 0.43*** -.77(.18) 0.46***   -.78(.20) 0.46*** 
     Road grade (1 = level) -.37(.12) 0.69** -.29(.18) 0.75   -.25(.20) 0.78 
     Surface condition (1 = dry) -.63(.18) 0.54** -.32(.28) 0.73   -.26(.32) 0.78 
     Surface type (1 = Asphalt) -.02(.17) 0.98  .05(.26) 1.05      .03(.28) 1.03 
     Intersection involved -.24(.14) 0.79† -.24(.22) 0.79   -.21(.24) 0.81 
     Posted speed limit -.03(.01) 0.97*** -.05(.01) 0.95***   -.04(.01) 0.96*** 
Drivers’ Vehicle Conditions       
     Vehicle  
       type 
Passenger vehicle 
(Reference) 
     --   -- -70(.25) 0.50**   -.29(.27) 0.75 
Heavy truck -.17(.32) 0.85     
Motorcycle 1.01(.15) 2.74***     
Others   .03(.55) 1.03     
Other External Conditions       
     Number of occupants in vehicle   .10(.06)  1.11† -.03(.10)  0.97   -.04(.11)  0.96 
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     Number of vehicles in crash -.26(.09) 0.78** -.35(.12) 0.71**   -.35(.13) 0.71** 
Drug and Alcohol Involvement       
     BAC < .080   .88(.20) 2.42***      --  --        --  -- 
     BAC > .080 1.18(.13) 3.26***      --  --        --  -- 
     THC < 5.00 -.05(.21) 0.95 -.25(.26) 0.78   -.22(.29) 0.80 
     THC > 5.00 .36(.17) 1.43* .35(.25) 1.42    .39(.28) 1.48 
     Carboxy only without THC .34(.19) 1.40† .48(.30) 1.62    .44(.32) 1.55 
     Other drugsa .45(.12) 1.57*** .29(.19) 1.34    .32(.21) 1.38 
      
Model χ2              639.536***              189.494*** 145.119*** 
Nagelkerke R2                   .376                   .299                     .281 
Note: No significant interaction terms in the models are found. OR = odds ratios. BAC = blood alcohol concentration. THC = delta-9-tetrahydrocannabinol. a other 1 
drugs include narcotics, depressants, stimulants, hallucinogens, phencyclindine, inhalants, and other unknown types of drugs. Sample sizes vary by models due to the 2 
use of a list-wise deletion method. 3 
† p <.1, *p <.05, **p <.01, ***p <.001 4 
 5 
 6 
The results for the sub-group analysis are somewhat consistent with the results for the speeding model presented above. The results from a 7 
model of blood tested drivers indicate that young males, driving a motorcycle, on curvy wet roads, who test positive for alcohol, Carboxy 8 
alone, and Delta-9-THC over 5 nanograms per mL, and other drugs, were more likely to be speeding when involved in a fatal crash, though 9 
some of these results are only marginally significant.  10 
            For the subset of drivers who tested positive for alcohol, the results similarly indicate that age, sex, and road conditions predict 11 
speeding during fatal crashes. Importantly, the variables Delta-9-THC, Carboxy, and other drugs are unrelated to speeding for alcohol 12 
positive drivers (both lesser and greater than or equal to 0.08 drivers). No significant interaction terms in the three sub-groups are found.  13 
 14 
Driver Error Models 15 
Results for the main effects and three interaction models where driver errors are regressed on driver characteristics, contextual factors, and 16 
drug and alcohol involvement are presented in Table 5. The results for the main effects model for driver errors are similar to the results for 17 
the speeding model presented above. Particularly, a number of driver characteristics (including expected risk factors, like age, unlicensed 18 
driver, and other prior traffic conviction) and contextual factors significantly predict driver error during a fatal crash. Similar to the findings 19 
from the speeding models, drivers with elevated BAC levels and drivers who tested positive for other drugs were significantly more likely 20 
to yield driver error during a fatal crash. However, while the presence of Carboxy was significantly and positively associated with driver 21 
error, the presence of Delta-9-THC is not significantly related to driver error. Indeed, drivers with Delta-9-THC in their blood that tested 22 
greater than or equal to 5.00 nanograms per mL were somewhat less likely to engage in driving error during a fatal crash, though this result 23 
only achieves marginal statistical significance. The interaction models reveal significant interactions between BAC > .08 and Carboxy and 24 
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other drugs, with all interactions suggesting that the combination of alcohol and other drugs seems to decrease the likelihood of driver error. 1 
This might indicate something of a self-correcting measure in that drivers under the influence of multiple substances might attempt to drive 2 
more carefully to compensate for the drugs effect. Alternatively, given that much of these data are derived from police reports, it is also 3 
possible that when an officer notes evidence of impairment that other smaller factors may be deemed less important and not recorded on 4 
the report. 5 
 6 
TABLE 5 Logit Models of Drug and Alcohol on Driver Errors (n = 5,455; drivers from 2008-2016 WA FARS data) 7 
 Main Effects Model Interaction Model 1 Interaction Model 2 Interaction Model 3 
Covariates      Logit 
(Robust SE) 
OR      Logit 
(Robust SE) 
OR      Logit 
(Robust SE) 
OR      Logit 
(Robust SE) 
 OR 
Driver Characteristics        
     Age -.00(.00) 1.00† -.00(.00) 1.00 -.00(.00) 1.00† -.05(.11) 1.00† 
     Gender (1 = male)  .12(.07) 1.13†  .12(.07) 1.13†   .11(.07) 1.12  .12(.07) 1.12 
     Unlicensed driver  .54(.10) 1.71***   .54(.10) 1.71***   .53(.10) 1.71***  .53(.10) 1.71*** 
     Other traffic conviction  
     (in the past three years) 
 .16(.07) 1.17*  .16(.07) 1.17*   .16(.07) 1.17*  .16(.07) 1.17* 
Natural Conditions         
     Time of crash (1 = night) -.34(.07) 0.71*** -.34(.07) 0.71*** -.35(.07) 0.70*** -.36(.07) 0.70*** 
Road Conditions       
     Asphalt   .19(.09) 1.21*   .19(.09) 1.21*   .19(.09) 1.21*  .19(.09) 1.22* 
     Posted speed limit  .01(.00) 1.01***  .01(.00) 1.01***   .01(.00) 1.01***  .01(.00) 1.01*** 
Drivers’ Vehicle Conditions       
Vehicle 
type 
Passenger vehicle 
(Reference) 
     --    --      --    --      --     --       --     --  
Heavy truck -1.41(.19) 0.24*** -1.41(.19) 0.24***  -1.40(.19) 0.25***  1.40(.19) 0.25***  
Motorcycle -.71(.11) 0.49*** -.72(.11) 0.49*** -.72(.11) 0.49*** -.73(.11) 0.48*** 
Others -.84(.29) 0.43** -.84(.29) 0.43** -.83(.29) 0.44* -.84(.29) 0.43** 
Other External Conditions       
     Number of vehicles in 
crash 
-.20(.04) 0.82*** -.20(.04) 0.82*** -.20(.04) 0.82*** -.20(.04) 0.82*** 
     Heavy truck involved   .56(.12) 1.76***  .57(.13) 1.76***  .56(.13) 1.76***  .57(.13) 1.76*** 
     Head-on involved   .64(.08) 1.89***  .64(.08) 1.89***  .63(.08) 1.88***  .63(.08) 1.87*** 
     Traffic control device 
present 
1.10(.09) 3.02*** 1.11(.09) 3.02*** 1.11(.09) 3.02*** 1.10(.09) 3.01*** 
     Lap and shoulder belt used -.33(.08) 0.72*** -.32(.08) 0.72*** -.31(.08) 0.74*** -.31(.08) 0.73*** 
Drug and Alcohol Involvement       
Woo, Willits, Stohr, Hemmens, Hoff   14 
 
14 | P a g e  
 
     BAC < .080  .77(.16) 2.16***  .77(.16) 2.15***  .76(.16) 2.13***  .76(.16) 2.13*** 
     BAC > .080  .76(.09) 2.14***  .80(.09) 2.22***  .94(.10) 2.57***  .93(.10) 2.52*** 
     THC < 5.00  .17(.18) 1.18  .16(.18) 1.17  .14(.18) 1.15  .14(.18) 1.15 
     THC > 5.00 -.28(.16) 0.75† -.29(.16) 0.75† -.31(.16) 0.73* -.31(.16) 0.73* 
     Carboxy only without THC  .66(.17) 1.93***  .92(.22) 2.51***  .88(.22) 2.42***  .88(.22) 2.42*** 
     Other drugsa  .40(.08) 1.49***  .39(.08) 1.48***  .58(.09) 1.78***  .58(.09) 1.78*** 
Interactions       
     BAC >.080*Carboxy     --  -- -.68(.34) 0.52† -.61(.33) .54†  -.31(.36) .73 
     BAC >.080*Other drugs     --  --      --   -- -.76(.19) .47*** -.66(.19) .52** 
     BAC >.080*Other 
drugs*Carboxy 
    --  --      --   --      --    -- -1.27(.62) .28* 
Model χ2      598.837***           602.716***             618.057***             622.614*** 
Nagelkerke R2            .143    .144       .148                   .149 
Note: Significant interaction terms in the models are presented. OR = odds ratios. BAC = blood alcohol concentration. THC = delta-9-tetrahydrocannabinol. a other 1 
drugs include narcotics, depressants, stimulant, hallucinogens, phencyclindine, inhalants, and other unknown types of drugs. Sample sizes vary by models due to the 2 
use of a list-wise deletion method. 3 
† p <.1, *p <.05, **p <.01, ***p <.001 4 
 5 
 6 
            Sub-group analyses were then conducted, including drivers who were given a blood test for drugs (n=2,251); 2) drivers who were 7 
given a blood test for drugs and tested positive for alcohol (n=783); and 3) drivers who were given a blood test for drugs and tested positive 8 
for alcohol greater than or equal to 0.08 (n=651). The results are presented in table 6. The results from a model of blood tested drivers 9 
indicate that unlicensed young males, who had other traffic conviction records, and those who test positive for alcohol or Carboxy were 10 
more likely to commit driver error when involved in a fatal crash, though again some of these results are only marginally significant. 11 
Interestingly, drivers who test positive for Delta-9 THC equal to or over 5.00 ng per mL are 38% less likely to make driver errors in fatal 12 
accidents than drivers who were blood tested and found to not have Delta-9-THC in their blood. 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
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TABLE 6 Sub-Group Analysis: Logit Models of Drug and Alcohol on Driver Errors 1 
Covariates 
Blood Tested Drivers 
(n=2,251) 
Interaction Model of Drug 
Tested Drivers (n=2,251) 
BAC Positive Drivers 
(n=783) 
BAC >.08 Drivers 
(n=651) 
     Logit 
(Robust SE) 
OR      Logit  
(Robust SE) 
OR      Logit  
(Robust SE) 
OR      Logit 
(Robust SE) 
OR 
Driver Characteristics        
     Age -.01(.00) 0.99** -.01(.00) 0.99** -.02(.01) 0.98*** -.02(.01) 0.98** 
     Gender (1 = male)   .13(.11) 1.14   .13(.11) 1.14 -.20(.20) 0.82  -.42(.23) 0.66†  
     Unlicensed driver   .37(.13) 1.45**    .36(.13) 1.44**  .56(.18) 1.75**  .60(.20) 1.82**  
     Other traffic conviction   .17(.10) 1.18†   .17(.10) 1.19† -.03(17) 0.97  .01(.18) 1.01 
Natural Conditions          
     Time of crash (1 = night) -.34(.10) 0.71** -.35(.10) 0.70** -.31(.18) 0.74 -.29(.21) 0.75 
Road Conditions       
     Asphalt   .15(.14) 1.16   .15(.14) 1.17   .33(.22) 1.39   .24(.24) 1.27 
     Posted speed limit  .01(.00) 1.01†   .01(.00) 1.01†   .01(.01) 1.01   .02(.01) 1.02*  
Drivers’ Vehicle Conditions       
Vehicle  
  type 
Passenger vehicle 
(Reference) 
     --   --      --   --   .44(.23) 1.55†   .50(.26) 1.65†     
Heavy truck -1.60(.30) 0.20*** -1.58(.30) 0.21***      
Motorcycle -.68(.15) 0.51*** -.67(.15) 0.51***     
Othersa -.99(.48) 0.37* -.99(.48) 0.37*     
Other External Conditions       
     Number of vehicles in crash  .17(.07) 1.19*   .16(.07) 1.18*   .23(.14) 1.26   .40(.17) 1.49* 
     Heavy truck involved  .65(.21) 1.92**   .66(.21) 1.93**   .87(.51) 2.38†    .66(.54) 1.94 
     Head-on involved  .94(.13) 2.56***   .94(.13) 2.55*** 1.50(.34) 4.49*** 1.49(.40) 4.45*** 
     Traffic control device present 1.12(.15) .08*** 1.12(.15) 3.08*** 1.45(.33) 4.28*** 1.53(.37) 4.63*** 
     Lap and shoulder belt used  .01(.11) 1.01   .02(.11) 1.02   .25(.18) 1.28   .24(.20) 1.27 
Drug and Alcohol Involvement        
     BAC < .080  .81(.20) 2.24***  .81(.20) 2.26***     --   --     --   -- 
     BAC > .080  .71(.12) 2.03***   .84(.14) 2.32***   --   --     --   -- 
     THC < 5.00 -.07(.18) 0.93 -.08(.18) 0.92 -.24(.27) 0.79 -.29(.31) 0.75 
     THC > 5.00 -.48(.16) 0.62** -.50(.16) 0.61** -.79(.23) 0.46** -.94(.26) 0.39*** 
     Carboxy only without THC  .43(.19) 1.53*  .41(.19) 1.50*   .42(.27) 1.52  .17(.29) 1.18 
     Other drugs  .13(.10) 1.14   .25(.12) 1.28* -.06(.18) 0.94 -.22(.20) 0.80 
Interactions       
     BAC >.080*Other drugs      --   -- -.42(.21) 0.66†      --   --      --   -- 
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Model χ2         306.301***           309.405***          132.768***         119.787*** 
Nagelkerke R2  .172    .174   .220   .243 
Note: Significant interaction terms in the models are presented. OR = odds ratios. BAC = blood alcohol concentration. THC = delta-9-tetrahydrocannabinol. a other 1 
drugs include narcotics, depressants, stimulants, hallucinogens, phencyclindine, inhalants, and other unknown types of drugs. Sample sizes vary by models due to the 2 
use of a list-wise deletion method. 3 
† p <.1, *p <.05, **p <.01, ***p <.001 4 
 5 
The results also indicate that drivers who were given a blood test were more likely to have been involved in head-on collision and 6 
with other vehicles, like heavy trucks, in a fatal crash. Notably, it might be that those involved in head-on collisions were more likely to be 7 
drug tested because they died. There is a marginally significant interaction between other drugs and BAC equal to or over the 0.08 limit. 8 
However, this interaction was negative, meaning that drivers who had consumed alcohol and tested positive for some other drug were less 9 
likely to commit driver error. The interaction, however, only provides modest improvements to model fit as evidenced by the small increases 10 
in Nagelkerke R2 values. 11 
            With regard to a model of BAC positive drivers, the results show that age, driving without a license, and using a passenger vehicle 12 
were positive risk factors driver error when involved in a fatal crash. The significance of prior traffic convictions and time of accident 13 
disappears in this sub-group analysis. In addition, the presence of other drugs and Carboxy is no longer associated with driver error. Delta-14 
9-THC, Carboxy, and other drugs have some mixed effects on driver error on these sub-group drivers and no significant interaction terms 15 
in the BAC positive sub-groups are found.16 
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DISCUSSION 1 
This study examined the degree to which those drivers tested positive for cannabis, measured both 2 
as Delta-9-THC and Carboxy in the blood, were related to speeding and driver error that may result 3 
in fatal crashes in Washington State. We hypothesized that cannabis use increases the likelihood 4 
that a driver involved in a fatal crash was speeding, and committed an error. Moreover, we 5 
hypothesized that the effects of Delta-9-THC and Carboxy on these outcomes are greater when 6 
used in conjunction with alcohol and/or other drugs.  7 
The results of this study were mixed. Delta-9-THC (over 5ng/mL) was positively 8 
associated with speeding, but Delta-9-THC (over 5ng/mL) was negatively related to driver error. 9 
The positive link between Delta-9-THC and speeding was particularly strong, as these results were 10 
statistically significant in the full model and for the subset of all drivers who were blood tested. It 11 
is important to note though that while this was a robust result, the relationship between Delta-9-12 
THC and speeding was than the relationship between alcohol and speeding, Carboxy and speeding, 13 
and other drug consumption and speeding. This suggests that while marijuana consumption is a 14 
risk factor for speeding, it is, like the research on marijuana and crashes suggest (4), a low to 15 
medium-level risk factor. Much like prior research, however, alcohol intoxication was a strong and 16 
positive predictor of speeding and driver error (8, 17, 33, 34). Again, while our results cannot speak 17 
to the etiology of crashes or fatal crashes, these results suggest that alcohol intoxication is more 18 
likely to result in driver errors in fatal accidents than cannabis consumption.  19 
The negative link between Delta-9-THC and driver errors was even weaker, as this was 20 
only significant in the full sample during interaction models and in the subset models including 21 
only drivers who were blood tested. Put simply, drivers with Delta-9-THC seemed marginally less 22 
likely to make driver errors in fatal crashes, but this effect was not particularly robust. At a surface 23 
level, the null or very weak negative relationship between Delta-9-THC and driver error might 24 
seem to run contrary to prior research which finds that cannabis intoxication is a risk factor for 25 
crashes. We caution against this interpretation, as our data consist of only crashes resulting in fatal 26 
injuries and therefore due to this selection bias cannot be used to identify predictors of non-fatal 27 
crashes generally. Instead, our results simply state that drivers in Washington who tested positive 28 
for Delta-9-THC were no more likely to commit an error included in the WA FARS data than 29 
drivers involved in fatal crashes in general. In fact, when examining the subset of blood tested 30 
drivers, individuals who tested positive for more than 5ng of Delta-9-THC were less likely than 31 
drivers who tested negative for Delta-9-THC to make driver errors. This result may in fact be in 32 
line with prior research, as it is possible that cannabis impaired drivers recognize their impairments 33 
(7, 17) and take active steps to drive slower and make less driving errors (35). There are other 34 
potential explanations for this result, however. It may be that police are less likely to note driver 35 
error’s during the crash reports when they suspect recent marijuana use, as it is possible that the 36 
evidence of drug consumption is enough to press forward with charges.  37 
Interestingly, the interaction of Delta-9-THC and alcohol and the interaction between 38 
Delta-9-THC and other drugs were not risk factors for speeding or driver error; in fact, these results 39 
have demonstrated only a modest, but negative, association with speeding. Sub-group analyses 40 
have also shown the null or very weak relationship between Delta-9-THC (above and below 41 
5ng/mL) and speeding. Our interactions and subgroup analyses suggest that the combination of 42 
recent cannabis consumption with other drugs or alcohol do not greatly impact the likelihood that 43 
a driver was speeding or made an error during a fatal crash. This seems to run contrary to prior 44 
work highlighting the interactive nature of marijuana and alcohol (8), though it is important to 45 
remember that our work only describes behavior during crashes and does not explain why the crash 46 
occurred in the first place. 47 
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These data do indicate that the per se limit for Delta-9-THC stood as a potential 1 
demarcation line on driver culpability, albeit with mixed results. As mentioned in the preceding 2 
discussion, in terms of speeding, Delta-9-THC over the 5 nanograms per mL limit  was strongly 3 
and statistically significantly related to speeding in both the main and interaction models (see Table 4 
3) as it was for Blood Tested Drivers in the sub-group analysis (see Table 4). For drivers who 5 
committed errors, the relationship with a Delta-9-THC level that met or exceeded the per se limit 6 
was more modestly, and paradoxically negatively, related in both the main and interaction models 7 
and in the sub-group analyses (see Tables 5 and 6). In contrast, Delta-9 THC levels that tested 8 
below the per se limit did not show up as statistically significantly related to either speeding or 9 
driver error in any of the models (with the exception of a modest and negative relationship with 10 
BAC Positive Drivers and Speeding – see Table 4). Clearly, replication of this kind of analysis is 11 
warranted before any conclusions can be drawn, but these findings do indicate there is a difference 12 
in outcomes when the level of Delta-9-THC intoxication varies. As already mentioned in this paper, 13 
the appropriate per se limit in the states is not a settled matter and this matter requires more 14 
attention as determining the point at which Delta-9 THC levels are most likely to result in driving 15 
impairment might be useful for policymakers as they grapple with whether a limit makes a 16 
difference and whether it is defensible in court.     17 
One of our most interesting results regards the relationship between Carboxy and driver 18 
behaviors during fatal crashes. These results indicate that drivers who had consumed cannabis 19 
recently, but not necessarily in the immediate time period before the crash, were significantly more 20 
likely to speed during a fatal accident and this effect was greater than for Delta-9-THC. Moreover, 21 
our results indicate that drivers who had consumed cannabis, but not recently, were also more 22 
likely to make driver errors during fatal crashes. This suggests that the link between cannabis use 23 
more generally and recent cannabis use and driving behaviors need not be the same.  24 
We cannot definitely explain why Carboxy has stronger and more deleterious effects on 25 
driving behaviors than Delta-9-THC, but we offer some suggestions for investigation in future 26 
research. One possibility is that Carboxy, given the length of time it remains in the bloodstream, 27 
is a proxy measure for regular cannabis use. If so, it is possible that cannabis use impairs cognitive 28 
functioning and thereby leads to poor driving decisions. Indeed, research suggests that persistent 29 
cannabis use may have both acute and long-term effects on decision-making (36, 37). The negative 30 
correlation between Delta-9-THC concentration and driving performance has been shown to be 31 
inconsistent and to vary for chronic versus occasional users (3), indicating that over time, regular 32 
cannabis users may become worse drivers. Alternatively, a positive result for Carboxy might 33 
simply be a proxy for impulsivity or low self-control. A large body of research links impulsivity 34 
to both drug consumption (38, 39) and risky behaviors, including risky driving behaviors (40, 41). 35 
This explanation moves the causal emphasis away from cannabis and suggests, instead, that both 36 
cannabis use and driving problems are the result of the same underlying personality traits and 37 
characteristics. It is important to note that FARS data are not suited for testing these explanations, 38 
as Carboxy is a crude proxy for variables like regular cannabis use and an even weaker proxy for 39 
cognitive functioning. More work is absolutely needed in this area.   40 
The current research suffers from a number of limitations. The WA FARS data only 41 
examine fatal crashes and therefore provide a sample of incidents in which driving, for whatever 42 
reason, has gone awry resulting in the death of a driver, passenger, or non-motorist. More research 43 
is needed on the effects of cannabis in a variety of driving contexts, including non-fatal crashes 44 
and traffic citations (not involving a crash). Moreover, the current analysis uses data only from 45 
Washington State. Though the WA FARS data provide more detailed drug information than the 46 
NHTSA FARS data, these results should be replicated in other states. Related to this, while the WA 47 
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FARS data is notable in their inclusion of drug-testing results, drug tests were not administered in 1 
all crashes. Though we suspect that crash investigators were likely to order testing if there was 2 
evidence of recent cannabis use, we cannot rule out measurement error in our key independent 3 
variables.  4 
 5 
CONCLUSIONS 6 
As more and more states experiment with the legalization and decriminalization of cannabis, it is 7 
important that research is conducted to examine the consequences for traffic safety. Our results are 8 
mixed. The consumption of cannabis appears to increase the likelihood that a driver was speeding 9 
during a fatal crashes, but only Carboxy, an inactive resultant chemical, is a risk factor for driver 10 
errors during fatal crashes. Thus, while we find some evidence that cannabis consumption is a risk 11 
factor for dangerous driving behaviors, we do not find uniform evidence of this. Moreover, the 12 
negative effect of cannabis as never as strong as the negative effect of alcohol in any of our models. 13 
Lastly, we find no evidence that cannabis interacts with alcohol or other substances to increase the 14 
likelihood of dangerous driving behaviors during fatal crashes. Even given these mixed results, it 15 
is clear that more work is needed in this area, especially on data which are not limited to only fatal 16 
crashes. In addition, we strongly suggest that additional work be conducted examining the link 17 
between Carboxy and driving behaviors, as the FARS data are not suited for addressing why the 18 
non-psychoactive metabolites produced by consuming cannabis are a bigger predictor of driver 19 
error than the primary psychoactive ingredient in cannabis. Given our analysis and the limitations 20 
of our data, we conclude by noting that there is evidence that cannabis use is associated with risky 21 
driving behaviors during fatal crashes, but that the effect is low to medium in size and that alcohol 22 
remains a much larger problem.   23 
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